Form: 10-K

Annual report pursuant to Section 13 and 15(d)

September 26, 2024

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the registration statements (No. 333-276267, 333-261874 and 333-253258) on Form S-8, registration statement (No. 333-277310) on Form S-3, and registration statements (No.333-279439, 333-273177, 333-268763 and 333-266417) on Form S-1 of Benitec Biopharma Inc. of our report dated September 26, 2024, relating to the consolidated financial statements of Benitec Biopharma Inc., appearing in this Annual Report on Form 10-K of Benitec Biopharma Inc. for the year ended June 30, 2024.

 

/s/ BAKER TILLY US, LLP
San Jose, California
September 26, 2024